Abstract
The last 40 years of molecular biological investigations into human adenoviruses have contributed enormously to our understanding of the basic principles of normal and malignant cell growth. Much of this knowledge stems from analyses of their productive infection cycle in permissive host cells. Also, initial observations concerning the carcinogenic potential of human adenoviruses subsequently revealed decisive insights into the molecular mechanisms of the origins of cancer, and established adenoviruses as a model system for explaining virus-mediated transformation processes. Today it is well established that cell transformation by human adenoviruses is a multistep process involving several gene products encoded in early transcription units 1A (E1A) and 1B (E1B). Moreover, a large body of evidence now indicates that alternative or additional mechanisms are engaged in adenovirus-mediated oncogenic transformation involving gene products encoded in early region 4 (E4) as well as epigenetic changes resulting from viral DNA integration. In particular, detailed studies on the tumorigenic potential of subgroup D adenovirus type 9 (Ad9) E4 have now revealed a new pathway that points to a novel, general mechanism of virus-mediated oncogenesis. In this chapter, we summarize the current state of knowledge about the oncogenes and oncogene products of human adenoviruses, focusing particularly on recent findings concerning the transforming and oncogenic properties of viral proteins encoded in the E1B and E4 transcription units.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ahn J-H, Hayward GS (1997) The major immediate-early proteins IE1 and IE2 of human cytomegalovirus colocalize with and disrupt PML-associated nuclear bodies at very early times in infected permissive cells. J Virol 71: 4599–4613
Ambinder RF (2000) Gammaherpesviruses and hit-and-run oncogenesis. Americ J Pathol 156: 1–3
Anderson CW, Schmitt RC, Smart JE, Lewis JB (1984) Early region 1B of adenovirus 2 encodes two coterminal proteins of 495 and 155 amino acid residues. J Virol 50: 387–396
Ankerst J, Jonsson N, Kjellen L, Norrby E, Sjogren HO (1974) Induction of mammary fibroadenomas in rats by adenovirus type 9. Int J Cancer 13: 286–290
Ankerst J, Jonsson N (1989) Adenovirus type 9-induced tumorigenesis in the rat mammary gland related to sex hormonal state. J Natl Cancer Inst 81: 294–298
Avvakumov N, Wheeler R, D’Halluin JC, Mymryk JS (2002) Comparative sequence analysis of the largest E1A proteins of human and simian adenoviruses. J Virol 76: 7968–7975
Babich A, Nevins JR (1981) The stability of early adenovirus mRNA is controlled by the viral 72 kd DNA-binding protein. Cell 26: 371–379
Ben-Israel H, Kleinberger T (2002) Adenovirus and cell cycle control. Front Biosci 7: D1369 - D1395
Bernards R, Houweling A, Schrier PI, Bos JL, van der Eb AJ (1982) Characterization of cells transformed by Ad5 Ad12 hybrid early region. Virology 120: 422–432
Bernards R, Schrier PI, Bos JL, Van der Eb AJ (1983) Role of adenovirus types 5 and 12 early region lb tumor antigens in oncogenic transformation. Virology 127: 4553
Bernards R, Schrier PI, Houweling A, Bos JL, van der Eb AJ, Zijistra M, Melief CJ (1983) Tumorigenicity of cells transformed by adenovirus type 12 by evasion of T-cell immunity. Nature 305: 776–779
Bernards R, de Leeuw MG, Vaessen MJ, Houweling A, van der Eb AJ (1984) Oncogenicity by adenovirus is not determined by the transforming region only. J Virol 50: 847–853
Bernards R, de Leeuw MG, Houweling A, van der Eb AJ (1986) Role of the adenovirus early region 1B tumor antigens in transformation and lytic infection. Virology 150: 126–139
Bird A (2002) DNA methylation patterns and epigenetic memory. Genes Dev 16:6–21 Blair GE, Hall KT (1998) Human adenoviruses: evading detection by cytotoxic T lymphocytes. Semin Virol 8: 387–397
Blair-Zajdel ME, Blair GE (1988) The intracellular distribution of the transformation-associated protein p53 in adenovirus-transformed rodent cells. Oncogene 2: 579–584
Blanton RA, Carter TH (1979) Autoregulation of adenovirus type 5 early gene ex-pression. III. Transcription studies in isolated nuclei. J Virol 29: 458–465
Bonin LR, McDougall JK (1997) Human cytomegalovirus IE2 86-kilodalton protein binds p53 but does not abrogate G1 checkpoint function. J Virol 71: 5861–5870
Boulanger PA, Blair GE (1991) Expression and interactions of human adenovirus on-coproteins. Biochem J 275: 281–299
Boyd JM, Subramanian T, Schaeper U, La Regina M, Bayley S, Chinnadurai G (1993) A region in the C-terminus of adenovirus 2 5 Ela protein is required for association with a cellular phosphoprotein and important for the negative modulation of T24-ras mediated transformation, tumorigenesis and metastasis. EMBO J 12: 469478
Boyd JM, Malstrom S, Subramanian T, Venkatesh LK, Schaeper U, Elangovan B, D’Sa Eipper C, Chinnadurai G (1994) Adenovirus E1B 19 kDa and Bd-2 proteins interact with a common set of cellular proteins. Cell 79: 341–351
Boyer JL, Rohleder K, Ketner G (1999) Adenovirus E4 34 k and E4 11 k inhibit double strand break repair and are physically associated with the cellular DNA-dependent protein kinase. Virology 263: 307–312
Boyer JL, Ketner G (2000) Genetic analysis of a potential zinc-binding domain of the adenovirus E4 34 k protein. J Biol Chem 275: 14969–14978
Brackmann KH, Green M, Wold WS, Cartas M, Matsuo T, Hashimoto S (1980) Identification and peptide mapping of human adenovirus type 2-induced early polypeptides isolated by twodimensional gel electrophoresis and immunoprecipitation. J Biol Chem 255: 6772–6779
Branton PE, Bayley ST, Graham FL (1985) Transformation by human adenoviruses. Biochim Biophys Acta 780: 67–94
Bridge E, Ketner G (1989) Redundant control of adenovirus late gene expression by early region 4. J Virol 63: 631–638
Bridge E, Ketner G (1990) Interaction of adenoviral E4 and Elb products in late gene expression. Virology 174: 345–353
Brusca JS, Jannun R, Chinnadurai G (1984) Efficient transformation of rat 3Y1 cells by human adenovirus type 9. Virology 136: 328–337
Byrd P, Brown KW, Gallimore PH (1982) Malignant transformation of human embryo retinoblasts by cloned adenovirus 12 DNA. Nature 298: 69–71
Carter TH, Blanton RA (1978a) Autoregulation of adenovirus type 5 early gene expression II. Effect of temperature-sensitive early mutations on virus RNA accumulation. J Virol 28: 450–456
Carter TH, Blanton RA (1978b) Possible role of the 72,000 dalton DNA-binding pro- tein in regulation of adenovirus type 5 early gene expression. J Virol 25: 664–674
Carvalho T, Seeler JS, Öhman K, Jordan P, Pettersson U, Akusjärvi G, Carmo Fonseca M, Dejean A (1995) Targeting of adenovirus E1A and E4–ORF3 proteins to nuclear matrix-associated PML bodies. J Cell Biol 131: 45–56
Cathomen T, Weitzman MD (2000) A functional complex of the adenovirus proteins E1B-55 kDa and E4orf6 is necessary to modulate the expression level of p53 but not its transcriptional activity. J Virol 74: 11407–11412
Chang LS, Shenk T (1990) The adenovirus DNA-binding protein stimulates the rate of transcription directed by adenovirus and adeno-associated virus promoters. J Virol 64: 2103–2109
Chauvin C, Suh M, Remy C, Benabid AL (1990) Failure to detect viral genomic sequences of three viruses (herpes simplex, simian virus 40 and adenovirus) in human and rat brain tumors. Ital J Neurol Sci 11: 347–357
Chiou SK, White E (1997) p300 binding by E1A cosegregates with p53 induction but is dispensable for apoptosis. J Virol 71: 3515–3525
Chlenski A, Ketels KV, Korovaitseva GI, Talamonti MS, Oyasu R, Scarpelli DG (2000) Organization and expression of the human zo-2 gene (tjp-2) in normal and neoplastic tissues. Biochim Biophys Acta 1493: 319–324
Cook JL, Lewis AM, Jr. (1979) Host response to adenovirus 2-transformed hamster embryo cells. Cancer Res 39: 1455–1461
Cook JL, Hibbs JB, Jr., Lewis AM, Jr. (1982) DNA virus-transformed hamster cell-host effector cell interactions: level of resistance to cytolysis correlated with tumorigenicity. Int J Cancer 30: 795–803
Cook JL, May DL, Lewis AM, Jr., Walker TA (1987) Adenovirus E1A gene induction of susceptibility to lysis by natural killer cells and activated macrophages in infected rodent cells. J Virol 61: 3510–3520
Cotran RS, P SL, Kumar V (1994) Robbins pathology basis of disease, 5th ed.W. B. Sau,der:. Co., Philadelphia, PA
Craven SE, Bredt DS (1998) PDZ proteins organize synaptic signaling pathways. Cell 93: 495–498
Cress WD, Nevins JR (1996) A role for a bent DNA structure in E2F-mediated transcription activation. Mol Cell Biol 16: 2119–2127
Cress WD, Nevins JR (1996) Use of the E2F transcription factor by DNA tumor virus regulatory proteins. Curr Top Microbiol Immunol 208: 63–78
Csata S, Kulcsar G, Dan P, Horvath J, Nasz I, Ongradi J, Verebelyi A (1982a) Adenovirus antibodies in tumorous diseases of the urogenital system. Acta Chir Acad Sci Hung 23: 15–22
Csata S, Kulcsar G, Horvath J, Nasz I, Ongradi J, Verebelyi A (1982b) Study of antibodies to adenoviruses in patients with tumors of the urogenital system. Int Urol Nephrol 14: 115–119
de Stanchina E, McCurrach ME, Zindy F, Shieh SY, Ferbeyre G, Samuelson AV, Prives C, Roussel MF, Sherr CJ, Lowe SW (1998) E1A signaling to p53 involves the p19(ARF) tumor suppressor. Genes Dev 12: 2434–2442
Debbas M, White E (1993) Wild-type p53 mediates apoptosis by E1A, which is inhibited by El B. Genes Dev 7: 546–554
Dix I, Leppard KN (1993) Regulated splicing of adenovirus type 5 E4 transcripts and regulated cytoplasmic accumulation of E4 mRNA. J Virol 67: 3226–3231
Dobner T, Horikoshi N, Rubenwolf S, Shenk T (1996) Blockage by adenovirus E4orf6 of transcriptional activation by the p53 tumor suppressor. Science 272: 1470–1473
Dobner T, Kzhyshkowska J (2001) Nuclear export of adenovirus RNA. Curr Top Mi-crobiol Immunol 259: 25–54
Dörfler W (1996) A new concept in adenoviral oncogenesis: integration of foreign DNA and its consequences. Biochim Biophys Acta 1288: F79 - F99
Doucas V, Ishov AM, Romo A, Juguilon H, Weitzman MD, Evans RM, Maul GG (1996) Adenovirus replication is coupled with the dynamic properties of the PML nuclear structure. Genes Dev 10: 196–207
Douglas JL, Gopalakrishnan S, Quinlan MP (1991) Modulation of transformation of primary epithelial cells by the second exon of the Ad5 E1Al2S gene. Oncogene 6: 2093–2103
Douglas JL, Quinlan MP (1995) Efficient nuclear localization and immortalizing ability, two functions dependent on the adenovirus type 5 (Ad5) E1A second exon, are necessary for cotransformation with Ad5 EiB but not with T24ras. J Virol 69: 8061–8065
Downey JF, Rowe DT, Bacchetti S, Graham FL, Bayley ST (1983) Mapping of a 14,000-dalton antigen to early region 4 of the human adenovirus 5 genome. J Virol 45: 514–523
Durnam DM, Menninger JC, Chandler SH, Smith PP, McDougall JK (1988) A fragile site in the human U2 small nuclear RNA gene cluster is revealed by adenovirus type 12 infection. Mol Cell Biol 8: 1863–1867
Eager KB, Williams J, Breiding D, Pan S, Knowles B, Appella E, Ricciardi RP (1985) Expression of histocompatibility antigens H-2 K, -D, and -L is reduced in adenovirus-12-transformed mouse cells and is restored by interferon gamma. Proc Natl Acad Sci USA 82: 5525–5529
Edbauer C, Lamberti C, Tong J, Williams J (1988) Adenovirus type 12 E1B 19-kilodalton protein is not required for oncogenic transformation in rats. J Virol 62: 3265–3273
Endter C, Kzhyshkowska J, Stauber R, Dobner T (2001) SUMO-1 modification required for transformation by adenovirus type 5 early region 1B 55-kDa oncoprotein. Proc Natl Acad Sci USA 98: 11312–11317
Esche H, Schilling R, Dörfler W (1979) In vitro translation of adenovirus type 12- specific mRNA isolated from infected and transformed cells. J Virol 30: 21–31
Esche H (1982) Viral gene products in adenovirus type 2-transformed hamster cells. J Virol 41: 1076–1082
Esche H, Siegman B (1982) Expression of early viral gene products in adenovirus type 12-infected and -transformed cells. J Gen Virol 60: 99–113
Ewald D, Li M, Efrat S, Auer G, Wall RJ, Furth PA, Hennighausen L (1996) Time-sensitive reversal of hyperplasia in transgenic mice expressing SV40 T antigen. Science 273: 1384–1386
Fallaux FJ, Kranenburg O, Cramer SJ, Houweling A, Van Ormondt H, Hoeben RC, Van Der Eb AJ (1996) Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors. Hum Gene Ther 7: 215–222
Fallaux FJ, Bout A, van der Velde I, van den Wollenberg DJ, Hehir KM, Keegan J, Auger C, Cramer SJ, van Ormondt H, van der Eb AJ, Valerio D, Hoeben RC (1998) New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses. Hum Gene Ther 9: 1909–1917
Fanning AS, Anderson JM (1999) PDZ domains: fundamental building blocks in the organization of protein complexes at the plasma membrane. J Cin Invest 103: 767–772
Farrow SN, White JH, Martinou I, Raven T, Pun KT, Grinham CJ, Martinou JC, Brown R (1995) Cloning of a bc1–2 homologue by interaction with adenovirus E1B 19 K. Nature 374: 731–733
Fernandez-Soria V, Bornstein R, Forteza J, Parada C, Sanchez-Prieto R, Ramon y Cajal S (2002) Inconclusive presence of adenovirus sequences in human leukemias and lymphomas. Oncol Rep 9: 897–902
Field SJ, Tsai FY, Kuo F, Zubiaga AM, Kaelin WG, Jr., Livingston DM, Orkin SH, Greenberg ME (1996) E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 85: 549–561
Fisher PB, Babiss LE, Weinstein IB, Ginsberg HS (1982) Analysis of type 5 adenovirus transformation with a cloned rat embryo cell line ( CREF ). Proc Natl Acad Sci USA 79: 3527–3531
Flint SJ, Gallimore PH, Sharp PA (1975) Comparison of viral RNA sequences in ade-novirus 2-transformed and lytically infected cells. J Mol Biol 96: 47–68
Flint SJ, Sambrook J, Williams JF, Sharp PA (1976) Viral nucleic acid sequences in transformed cells. IV. A study of the sequences of adenovirus 5 DNA and RNA in four lines of adenovirus 5-transformed rodent cells using specific fragments of the viral genome. Virology 72: 456–470
Flint SJ, Sharp PA (1976) Adenovirus transcription. V. Quantitation of viral RNA se-quences in adenovirus 2-infected and transformed cells. J Mol Biol 106: 749–771
Flint SJ (1982) Organization and expression of viral genes in adenovirus-trans-formed cells. Int Rev Cytol 76: 47–65
Freyer GA, Katoh Y, Roberts RJ (1984) Characterization of the major mRNAs from adenovirus 2 early region 4 by cDNA cloning and sequencing. Nucl Acids Res 12: 3503–3519
Gabler S, Schutt H, Groitl P, Wolf H, Shenk T, Dobner T (1998) E1B 55-kilodaltonassociated protein: a cellular protein with RNA-binding activity implicated in nucleocytoplasmic transport of adenovirus and cellular mRNAs. J Virol 72: 79607971
Gallimore PH (1972) Tumour production in immunosuppressed rats with cells transformed in vitro by adenovirus type 2. J Gen Virol 16: 99–102
Gallimore PH, Byrd P, Grand RJ, Whittaker JL, Breiding D, Williams J (1984) An examination of the transforming and tumor-inducing capacity of a number of adenovirus type 12 early region 1, hostrange mutants and cells transformed by subgenomic fragments of Ad12 El region. Cancer Cells 2: 519–526
Gallimore PH, Grand RJ, Byrd PJ (1986) Transformation of human embryo retinoblasts with simian virus 40, adenovirus and ras oncogenes. Anticancer Res 6: 499508
Gallimore PH, Lecane PS, Roberts S, Rookes SM, Grand RJA, Parkhill J (1997) Adenovirus type 12 early region 1B 54 K protein significantly extends the life span of normal mammalian cells in culture. J Virol 71: 6629–6640
Gallimore PH, Turnell AS (2001) Adenovirus E1A: remodelling the host cell, a life or death experience. Oncogene 20: 7824–7835
Galloway DA, McDougall JK (1983) The oncogenic potential of herpes simplex viruses: evidence for a `hit-and-run’ mechanism. Nature 302: 21–24
Gardiol D, Kuhne C, Glaunsinger BA, Lee SS, Javier RT, Banks L (1999) Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation. Oncogene 18: 5487–5496
Gelb L, Dohner D (1984) Varicella-zoster virus-induced transformation of mammalian cells in vitro. J Invest Dermatol 83:77s-81 s
Gilead Z, Arens MQ, Bhaduri S, Shanmugam G, Green M (1975) Tumour antigen specificity of a DNA-binding protein from cells infected with adenovirus 2. Nature 254: 533–536
Ginsberg HS, Ensinger MJ, Kauffman RS, Mayer AJ, Lundholm U (1975) Cell transformation: a study of regulation with types 5 and 12 adenovirus temperature-sensitive mutants. Cold Spring Harb Symp Quant Biol: 419–426
Glaunsinger BA, Lee SS, Thomas M, Banks L, Javier RT (2000) Interactions of the PDZ-protein MAGI-1 with adenovirus E4–ORF1 and high-risk papillomavirus E6 oncoproteins. Oncogene 19: 5270–5280
Glaunsinger BA, Weiss RS, Lee SS, Javier RT (2001) Link of the unique oncogenic properties of adenovirus type 9 E4–ORF1 to a select interaction with the candidate tumor suppressor protein ZO-2. EMBO J 20: 5578–5586
Goodrum FD, Shenk T, Ornelles DA (1996) Adenovirus early region 4 34-kilodalton protein directs the nuclear localization of the early region 1B 55-kilodalton protein in primate cells. J Virol 70: 6323–6335
Goodrum FD, Ornelles DA (1997) The early region 1B 55-kilodalton oncoprotein of adenovirus relieves growth restrictions imposed on viral replication by the cell cycle. J Virol 71: 548–561
Goodrum FD, Ornelles DA (1998) p53 status does not determine outcome of E1B 55Kilodalton mutant adenovirus lytic infection. J Virol 72: 9479–9490
Goodrum FD, Ornelles DA (1999) Roles for the E4 orf6, orf3, and E1B 55-kilodalton proteins in cell cycle-independent adenovirus replication. J Virol 73: 7474–7488
Graham FL, Smiley J, Russel WC, Nairn R (1977) Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36: 59–72
Graham FL (1984) Transformation by and oncogenicity of human adenoviruses. In:Ginsberg HS (ed) The adenoviruses. Plenum Press, New York, pp 339–398
Grand RJ, Grant ML, Gallimore PH (1994) Enhanced expression of p53 in human cells infected with mutant adenoviruses. Virology 203: 229–240
Grand RJ, Parkhill J, Szestak T, Rookes SM, Roberts S, Gallimore PH (1999) Definition of a major p53 binding site on Ad2E1B58 K protein and a possible nuclear localization signal on the Ad12E1B54 K protein. Oncogene 18: 955–965
Green M, Wold WSM, Mackey JK, Ridgen P (1979) Analysis of human tonsils and cancer DNAs and RNAs for DNA sequences of group C (serotypes 1,2,5, and 6) human adenoviruses. Proc Natl Acad Sci USA 76: 6606–6610
Green M, Wold WSM, Brackmann KH (1980) Human adenoviruses transforming genes: group relationships, integration, expression in transformed cells and analysis of human cancers and tonsils. In: Essex M, Toardo G, zur Hausen H (eds) 7th Cold Spring Harbor conference on cell proliferation viruses in naturally occuring tumors. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, pp 373–397
Grossman SR, Perez M, Kung AL, Joseph M, Mansur C, Xiao Z-X, Kumar S, Howley PM, Livingston DM (1998) p300 MDM 2 complexes participate in MDM 2-mediated p53 degradation. Mol Cell 2: 405–415
Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, Weinberg RA (1999) Creation of human tumour cells with defined genetic elements. Nature 400: 464–468
Halbert DN, Cutt JR, Shenk T (1985) Adenovirus early region 4 encodes functions required for efficient DNA replication, late gene expression, and host cell shutoff. J Virol 56: 250–257
Haley KP, Overhauser J, Babiss LE, Ginsberg HS, Jones NC (1984) Transformation properties of type 5 adenovirus mutants that differentially express the E1A gene products. Proc Natl Acad Sci USA 81: 5734–5738
Han J, Sabbatini P, Perez L, Modha D, White E (1996) The E1B 19 K protein blocks apoptosis by interacting with and inhibiting the p53-inducible and death-promoting Bax protein. Genes Dev: 461–477
Harada JN, Shevchenko A, Pallas DC, Berk AJ (2002) Analysis of the adenovirus E1B–55K-anchored proteome reveals its link to ubiquitination machinery. J Virol 76: 9194–9206
Hardy S, Engel DA, Shenk T (1989) An adenovirus early region 4 gene product is required for induction of the infection-specific form of cellular E2F activity. Genes Dev 3: 1062–1074
Hardy S, Shenk T (1989) E2F from adenovirus-infected cells binds cooperatively to DNA containing two properly oriented and spaced recognition sites. Mol Cell Biol 9: 4495–4506
Hateboer G, Hijmans EM, Nooij JB, Schlenker S, Jentsch S, Bernards R (1996) mUBC9, a novel adenovirus E1A-interacting protein that complements a yeast cell cycle defect. J Biol Chem 271: 25906–25011
Henry H, Thomas A, Shen Y, White E (2002) Regulation of the mitochondrial checkpoint in p53-mediated apoptosis confers resistance to cell death. Oncogene 21: 748–760
Herisse J, Rigolet M, de Dinechin SD, Galibert F (1981) Nucleotide sequence of adenovirus 2 DNA fragment encoding for the carboxylic region of the fiber protein and the entire E4 region. Nucl Acids Res 9: 4023–4042
Honda R, Yasuda H (1999) Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53. EMBO J 18: 22–27
Hopfner KP, Putnam CD, Tainer JA (2002) DNA double-strand break repair from head to tail. Curr Opin Struct Biol 12: 115–122
Horikoshi N, Usheva A, Chen J, Levine AJ, Weinmann R, Shenk T (1995) Two domains of p53 interact with the TATA-binding protein, and the adenovirus 13S E1A protein disrupts the association, relieving p53-mediated transcriptional repression. Mol Cell Biol 15: 227–234
Huang MM, Hearing P (1989) Adenovirus early region 4 encodes two gene products with redundant effects in lytic infection. J Virol 63: 2605–2615
Huang MM, Hearing P (1989) The adenovirus early region 4 open reading frame 6 7 protein regulates the DNA binding activity of the cellular transcription factor, E2F, through a direct complex. Genes Dev 3: 1699–1710
Hutton FG, Turnell AS, Gallimore PH, Grand RJ (2000) Consequences of disruption of the interaction between p53 and the larger adenovirus early region 1B protein in adenovirus El transformed human cells. Oncogene 19: 452–462
Huvent I, Cousin C, Kiss A, Bernard C, D’Halluin JC (1996) Susceptibility to natural killer cells and down regulation of MHC class I expression in adenovirus 12 transformed cells are regulated by different E1A domains. Virus Res 45: 123–134
Hwang CB, Shilitoe EJ (1990) DNA sequence of mutations induced in cells by herpes simplex virus type-1. Virology 178: 180–188
Ibelgaufts H (1982) Are human DNA tumour viruses involved in the pathogenesis of human neurogenic tumours? Neurosurg Rev 5: 3–24
Ibelgaufts H, Jones KW, Maitland N, Shaw JF (1982) Adenovirus-related RNA sequences in human neurogenic tumours. Acta Neuropathol Berl 56: 113–117
Ishidate T, Matsumine A, Toyoshima K, Akiyama T (2000) The APC-hDLG complex negatively regulates cell cycle progression from the GO G1 to S phase. Oncogene 19: 365–372
Iwasaka T, Hayashi Y, Yokoyama M, Hara K, Matsuo N, Sugimori H (1992) `Hit and run’ oncogenesis by human papillomavirus type 18 DNA. Acta Obstet Gynecol Scand 71:219–223
Javier RT, Raska K, Jr., Macdonald GJ, Shenk T (1991) Human adenovirus type 9-induced rat mammary tumors. J Virol 65: 3192–3202
Javier RT, Raska K, Jr., Shenk T (1992) Requirement for the adenovirus type 9 E4 region in production of mammary tumors. Science 257: 1267–1271
Javier RT (1994) Adenovirus type 9 E4 open reading frame 1 encodes a transforming protein required for the production of mammary tumors in rats. J Virol 68: 39173924
Jelinek T, Pereira DS, Graham FL (1994) Tumorigenicity of adenovirus-transformed rodent cells is influenced by at least two regions of adenovirus type 12 early region 1A. J Virol 68: 888–896
Jeng YH, Wold WS, Green M (1978) Evidence for an adenovirus type 2-coded early glycoprotein. J Virol 28: 314–323
Jochemsen AG, Bernards R, van Kranen HJ, Houweling A, Bos JL, van der Eb AJ (1986) Different activities of the adenovirus types 5 and 12 E1A regions in transformation with the EJ Ha-ras oncogene. J Virol 59: 684–691
Johnson DG, Cress WD, Jakoi L, Nevins JR (1994) Oncogenic capacity of the E2F1 gene. Proc Natl Acad Sci USA 91: 12823–12827
Jones C (1995) Cervical cancer: is herpes simplex virus type II a cofactor? Clin Microbiol Rev 8: 549–556
Jones PA (1999) The DNA methylation paradox. Trends in Genetics 15: 34–37
Jonsson N, Ankerst J (1977) Studies on adenovirus type 9-induced mammary fi-broadenomas in rats and their malignant transformation. Cancer 39: 2513–2519
Jox A, Rohen C, Belge G, Bartnitzke S, Pawlita M, Diehl V, Bullerdiek J, Wolf J (1997)
Integration of Epstein-Barr virus in Burkitt’s lymphoma cells leads to a region of enhanced chromosome instability. Ann Oncol 8:131–135
Karran L, Teo CG, King D, Hitt MM, Gao YN, Wedderburn N, Griffin BE (1990) Establishment of immortalized primate epithelial cells with sub-genomic EBV DNA. Int J Cancer 45: 763–772
Kast WM, Offringa R, Peters PJ, Voordouw AC, Meloen RH, van der Eb AJ, Melief CJ (1989) Eradication of adenovirus El-induced tumors by E1A-specific cytotoxic T lymphocytes. Cell 59: 603–614
Kimelman D (1986) A novel general approach to eucaryotic mutagenesis functionally identifies conserved regions within the adenovirus 13S E1A polypeptide. Mol Cell Biol 6: 1487–1496
Kiyono T, Hiraiwa A, Fujita M, Hayashi Y, Akiyama T, Ishibashi M (1997) Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein. Proc Natl Acad Sci USA 94: 11612–11616
König C, Roth J, Dobbelstein M (1999) Adenovirus type 5 E4orf3 protein relieves p53 inhibition by E1B-55-kilodalton protein. J Virol 73: 2253–2262
Kovesdi I, Reichel R, Nevins JR (1986a) Identification of a cellular transcription factor involved in E1A trans-activation. Cell 45: 219–228
Kovesdi I, Reichel R, Nevins JR (1986b) E1A transcription induction: enhanced binding of a factor to upstream promoter sequences. Science 231: 719–722
Kovesdi I, Reichel R, Nevins JR (1987) Role of an adenovirus E2 promoter binding factor in ElAmediated coordinate gene control. Proc Natl Acad Sci USA 84: 21802184
Krätzer F, Rosorius O, Heger P, Hirschmann N, Dobner T, Hauber J, Stauber RH (2000) The adenovirus type 5 E1B-55 k oncoprotein is a highly active shuttle protein and shuttling is independent of E4orf6, p53 and Mdm2. Oncogene 19: 850857
Kuhlmann I, Achten S, Rudolph R, Dörfler W (1982) Tumor induction by human adenovirus type 12 in hamsters: loss of the viral genome from adenovirus type 12-induced tumor cells is compatible with tumor formation. EMBO J 1: 79–86
Kuwano K, Kawasaki M, Kunitake R, Hagimoto N, Nomoto Y, Matsuba T, Nakanishi Y, Hara N (1997a) Detection of group C adenovirus DNA in small-cell lung cancer with the nested polymerase chain reaction. J Cancer Res Clin Oncol 123: 377–382
Kuwano K, Nomoto Y, Kunitake R, Hagimoto N, Matsuba T, Nakanishi Y, Hara N (1997b) Detection of adenovirus E1A DNA in pulmonary fibrosis using nested polymerase chain reaction. Eur Respir J 10: 1445–1449
Kzhyshkowska J, Schutt H, Liss M, Kremmer E, Stauber R, Wolf H, Dobner T (2001) Heterogeneous nuclear ribonucleoprotein E1B-AP5 is methylated in its RGG-box and interacts with human arginine methyltransferase HRMT1L1. Biochem J 358: 305–314
Lawler M, Humphries P, O’Farrelly C, Hoey H, Sheils O, Jeffers M, O’Briain DS, Kelleher D (1994) Adenovirus 12 E1A gene detection by polymerase chain reaction in both the normal and coeliac duodenum. Gut 35: 1226–1232
Lee SS, Weiss RS, Javier RT (1997) Binding of human virus oncoproteins to hDlg SAP97, a mammalian homolog of the Drosophila discs large tumor suppressor protein. Proc Natl Acad Sci USA 94: 6670–6675
Lee SS, Glaunsinger BA, Mantovani F, Banks L, Javier RT (2000) Multi-PDZ domain protein MUPP1 is a cellular target for both adenovirus E4–ORF1 and high-risk papillomavirus type 18 E6 oncoproteins. J Virol 74: 9680–9693
Legrand A, Mayer EP, Dalvi SS, Nachtigal M (1997) Transformation of rabbit vascular smooth muscle cells by human cytomegalovirus morphological transforming region I. Am J Pathol 151: 1387–1395
Leppard KN, Everett RD (1999) The adenovirus type 5 Elb 55 K and E4 Orf3 proteins associate in infected cells and affect ND10 components. J Gen Virol 80: 9971008
Lethbridge KJ, Scott GE, Leppard KN (2003) Nuclear matrix localization and SUMO-1 modification of adenovirus type 5 Elb 55 K protein are controlled by E4 Orf6 protein. J Gen Virol 84: 259–268
Levinson A, Levine AJ, Anderson S, Osborn M, Rosenwirth B, Weber K (1976) The relationship between group C adenovirus tumor antigen and the adenovirus single-strand DNA-binding protein. Cell 7: 575–584
Lewis AM, Jr., Cook JL (1982) Spectrum of tumorigenic phenotypes among adenovirus 2-, adenovirus 12-, and simian virus 40-transformed Syrian hamster cells defined by host cellular immune-tumor cell interactions. Cancer Res 42: 939–944
Li Z, Yu A, Weiner AM (1998) Adenovirus type 12-induced fragility of the human RNU2 locus requires p53 function. J Virol 72: 4183–4191
Liao D, Yu A, Weiner AM (1999) Coexpression of the adenovirus 12 E1B 55 kDa oncoprotein and cellular tumor suppressor p53 is sufficient to induce metaphase fragility of the human RNU2 locus. Virology 254: 11–23
Liu Y, Colosimo AL, Yang XJ, Liao D (2000) Adenovirus E1B 55-kilodalton oncoprotein inhibits p53 acetylation by PCAF. Mol Cell Biol 20: 5540–5553
Logan J, Nicolas JC, Topp WC, Girard M, Shenk T, Levine AJ (1981) Transformation by adenovirus early region 2A temperature-sensitive mutants and their revertants. Virology 115: 419–422
Lowe SW, Ruley HE (1993) Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. Genes Dev 7: 535–545
Mackey JK, Rigden PM, Green M (1976) Do highly oncogenic group A human adenoviruses cause human cancer? Analysis of human tumors for adenovirus 12 transforming DNA sequences. Proc Natl Acad Sci USA 73: 4657–4661
Mackey JK, Green M, Wold WSM, Ridgen P (1979) Analysis of human cancer DNA for DNA sequences of human adenovirus type 4. J Natl Cancer Inst 62: 23–26
Maheswaran S, Englert C, Lee SB, Ezzel RM, Settleman J, Haber DA (1998) E1B 55 K sequesters WT1 along with p53 within a cytoplasmic body in adenovirus-transformed kidney cells. Oncogene 16: 2041–2050
Maitland NJ, Kinross JH, Busuttil A, Ludgate SM, Smart GE, Jones KW (1981) The detection of DNA tumour virus-specific RNA sequences in abnormal human cervical biopsies by in situ hybridization. J Gen Virol 55: 123–137
Marengo C, Mbikay M, Weber J, Thirion JP (1981) Adenovirus-induced mutations at the hypoxanthine phosphoribosyltransferase locus of Chinese hamster cells. J Virol 38: 184–190
Martin ME, Berk AJ (1999) Corepressor required for adenovirus E1B 55,000-molecu- lar-weight protein repression of basal transcription. Mol Cell Biol 19: 3403–3414
Marton MJ, Bairn SB, Ornelles DA, Shenk T (1990) The adenovirus E4 17-kilodalton protein complexes with the cellular transcription factor E2F, altering its DNA-binding properties and stimulating E1A-independent accumulation of E2 mRNA. J Virol 64: 2345–2359
McLorie W, McGlade CJ, Takayesu D, Branton PE (1991) Individual adenovirus E1B proteins induce transformation independently but by additive pathways. J Gen Virol 72: 1467–1471
Meijer I, Jochemsen AG, de Wit CM, Bos JL, Morello D, van der Eb AJ (1989) Adenovirus type 12 E1A down regulates expression of a transgene under control of a major histocompatibility complex class I promoter: evidence for transcriptional control. J Virol 63: 4039–4042
Miller BW, Williams J (1987) Cellular transformation by adenovirus type 5 is influenced by the viral DNA polymerase. J Virol 61: 3630–3634
Moore M, Horikoshi N, Shenk T (1996) Oncogenic potential of the adenovirus E4orf6 protein. Proc Natl Acad Sci USA 93: 11295–11301
Moran E, Grodzicker T, Roberts RJ, Mathews MB, Zerler B (1986) Lytic and transforming functions of individual products of the adenovirus E1A gene. J Virol 57: 765–775
Moran E (1994) Mammalian cell growth controls reflected through protein interac-tions with the adenovirus E1A gene products. Semin Virol 5: 327–340
Mukai N, Murao T (1975) Retinal tumor induction by ocular inoculation of human adenovirus in 3 day old rats. J Neuropathol Exp Neurol 34: 28–35
Mukai N, Kalter SS, Cummins LB, Matthews VA, Nishida T, Nakajima T (1980) Retinal tumor induced in the baboon by human adenovirus 12. Science 210: 10231025
Mushinski JF, Potter M, Bauer SR, Reddy EP (1983) DNA rearrangement and altered RNA expression of the c-myb oncogene in mouse plasmacytoid lymphosarcomas. Science 220: 795–798
Nakao M (2001) Epigenetics: interaction of DNA methylation and chromatin. Gene 278: 25–31
Neill SD, Hemstrom C, Virtanen A, Nevins JR (1990) An adenovirus E4 gene product transactivates E2 transcription and stimulates stable E2F binding through a direct association with E2F. Proc Natl Acad Sci USA 87: 2008–2012
Neill SD, Nevins JR (1991) Genetic analysis of the adenovirus E4 6 7 trans activator: interaction with E2F and induction of a stable DNA-protein complex are critical for activity. J Virol 65: 5364–5373
Nevels M, Rubenwolf S, Spruss T, Wolf H, Dobner T (1997) The adenovirus E4orf6 protein can promote E1A E1B-induced focus formation by interfering with p53 tumor suppressor function. Proc Natl Acad Sci USA 94: 1206–1211
Nevels M, Täuber B, Kremmer E, Spruss T, Wolf H, Dobner T (1999a) Transforming potential of the adenovirus type 5 E4orf3 protein. J Virol 73: 1591–1600
Nevels M, Spruss T, Wolf H, Dobner T (1999b) The adenovirus E4orf6 protein contributes to malignant transformation by antagonizing E1A-induced accumulation of the tumor suppressor protein p53. Oncogene 18: 9–17
Nevels M, Rubenwolf S, Spruss T, Wolf H, Dobner T (2000) Two distinct activities contribute to the oncogenic potential of the adenovirus type 5 E4orf6 protein. J Virol 74: 5168–5181
Nevels M, Täuber B, Spruss T, Wolf H, Dobner T (2001) “Hit-and-run” transformation by adenovirus oncogenes. J Virol 75:3089–3094
Nicolas AL, Munz PL, Falck-Pedersen E, Young CSH (2000) Creation and repair of specific DNA double-strand breaks in vivo following infection with adenovirus vectors expressing Saccharomyces cerevisiae HO endonuclease. Virology 266: 211–224
O’Connor RJ, Hearing P (1991) The C-terminal 70 amino acids of the adenovirus E4–ORF6 7 protein are essential and sufficient for E2F complex formation. Nucl Acids Res 19: 6579–6586
O’Connor RJ, Hearing P (2000) The E4–6 7 protein functionally compensates for the loss of E1A expression in adenovirus infection. J Virol 74: 5819–5824
Obert S, O’Connor RJ, Schmid S, Hearing P (1994) The adenovirus E4–6 7 protein transactivates the E2 promoter by inducing dimerization of a heteromeric E2F complex. Mol Cell Biol 14: 1333–1346
Öhman K, Nordquist K, Linder S, Akusjärvi G (1995) Effect of adenovirus-2 early region 4 products on El transformation. Int J Oncol 6: 663–668
Ornelles DA, Shenk T (1991) Localization of the adenovirus early region 1B 55-kilodalton protein during lytic infection: association with nuclear viral inclusions requires the early region 4 34-kilodalton protein. J Virol 65: 424–429
Pääbo S, Severinsson L, Andersson M, Martens I, Nilsson T, Peterson PA (1989) Adenovirus proteins and MHC expression. Adv Cancer Res 52: 151–163
Paraskeva C, Gallimore PH (1980) Tumorigenicity and in vitro characteristics of rat liver epithelial cells and their adenovirus-transformed derivatives. Int J Cancer 25: 631–639
Paraskeva C, Brown KW, Dunn AR, Gallimore PH (1982) Adenovirus type 12-transformed rat embryo brain and rat liver epithelial cell lines: adenovirus type 12 genome content and viral protein expression. J Virol 44: 759–764
Paraskeva C, Roberts C, Biggs P, Gallimore PH (1983) Human adenovirus type 2 but not adenovirus type 12 is mutagenic at the hypoxanthine phosphoribosyltransferase locus of cloned rat liver epithelial cells. J Virol 46: 131–136
Pereira DS, Rosenthal KL, Graham FL (1995) Identification of adenovirus E1A regions which affect MHC class I expression and susceptibility to cytotoxic T lymphocytes. Virology 211: 268–277
Persson H, Kvist S, Ostberg L, Peterson PA, Philipson L (1979) The early adenovirus glycoprotein E3–19 K and its association with transplantation antigens. Cold Spring Harb Symp Quant Biol 44: 509–514
Pfeffer A, Schubbert R, Orend G, Hilger-Eversheim K, Doerfler W (1999) Integrated viral genomes can be lost from adenovirus type 12-induced hamster tumor cells in a clone-specific, multistep process with retention of the oncogenic phenotype. Virus Res 59: 113–127
Punga T, Akusjärvi G (2000) The adenovirus-2 E1B-55 K protein interacts with a mSin3A histone deacetylase 1 complex. FEBS Lett 476: 248–252
Querido E, Marcellus RC, Lai A, Rachel C, Teodoro JG, Ketner G, Branton PE (1997) Regulation of p53 levels by the E1B 55-kilodalton protein and E4orf6 in adenovirus-infected cells. J Virol 71: 3788–3798
Querido E, Blanchette P, Yan Q, Kamura T, Morrison M, Boivin D, Kaelin WG, Conaway RC, Conaway JW, Branton PE (2001) Degradation of p53 by adenovirus E4orf6 and E1B55 K proteins occurs via a novel mechanism involving a Cullincontaining complex. Genes Dev 15: 3104–3017
Querido E, Morisson MR, Chu-Pham-Dang H, Thirlwell SW, Boivin D, Branton PE (2001) Identification of three functions of the adenovirus E4orf6 protein that mediate p53 degradation by the E4orf6-E1B55 K complex. J Virol 75: 699–709
Quinlan MP, Douglas JL (1992) Immortalization of primary epithelial cells requires first-and second-exon functions of adenovirus type 5 12S. J Virol 66: 2020–2030
Rao L, Debbas M, Sabbatini P, Hockenbery D, Korsmeyer S, White E (1992) The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bc1–2 proteins. Proc Natl Acad Sci USA 89: 7742–7746
Raska K, Jr., Gallimore PH (1982) An inverse relation of the oncogenic potential of adenovirus-transformed cells and their sensitivity to killing by syngeneic natural killer cells. Virology 123: 8–18
Raychaudhuri P, Bagchi S, Nevins JR (1989) DNA-binding activity of the adenovirusinduced E4F transcription factor is regulated by phosphorylation. Genes Dev 3: 620–627
Reichel R, Neill SD, Kovesdi I, Simon MC, Raychaudhuri P, Nevins JR (1989) The adenovirus E4 gene, in addition to the E1A gene, is important for trans-activation of E2 transcription and for E2F activation. J Virol 63: 3643–3650
Ricciardi RP (1995) Transformation and tumorigenesis mediated by the adenovirus E1A and E1B oncogenes. In: Barbanti-Brodano G (ed) DNA Tumor Viruses: Oncogenic Mechanisms. Plenum Press, New York, pp 195–210
Ricciardi RP (1999) Adenovirus transformation and tumorigenicity. In: Seth P (ed) Adenoviruses: Basic biology to gene therapy. RG Landes Co, Austin, pp 217–227
Rice SA, Klessig DF, Williams J (1987) Multiple effects of the 72-kDa, adenovirusspecified DNA binding protein on the efficiency of cellular transformation. Virology 156: 366–376
Ross D, Ziff E (1992) Defective synthesis of early region 4 mRNAs during abortive adenovirus infections in monkey cells. J Virol 66: 3110–3117
Roth J, König C, Wienzek S, Weigel S, Ristea S, Dobbelstein M (1998) Inactivation of p53 but not p73 by adenovirus type 5 E1B 55-Kilodalton and E4 34-Kilodalton oncoproteins. J Virol 72: 8510–8516
Ruley HE (1983) Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture. Nature 304: 602–606
Sabbatini P, Chiou SK, Rao L, White E (1995) Modulation of p53-mediated transcriptional repression and apoptosis by the adenovirus E1B 19 K protein. Mol Cell Biol 15: 1060–1070
Sabbatini P, Lin J, Levine AJ, White E (1995) Essential role for p53-mediated transcription in ElAinduced apoptosis. Genes Dev 9: 2184–2192
Sarnow P, Hearing P, Anderson CW, Reich N, Levine AJ (1982) Identification and characterization of an immunologically conserved adenovirus early region 11,000 Mr protein and its association with the nuclear matrix. J Mol Biol 162: 565–583
Sarnow P, Ho YS, Williams J, Levine AJ (1982) Adenovirus Elb-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells. Cell 28: 387–394
Sawada Y, Fohring B, Shenk TE, Raska K, Jr. (1985) Tumorigenicity of adenovirustransformed cells: region E1A of adenovirus 12 confers resistance to natural killer cells. Virology 147: 413–421
Sawada Y, Raska K, Jr., Shenk T (1988) Adenovirus type 5 and adenovirus type 12 recombinant viruses containing heterologous El genes are viable, transform rat cells, but are not tumorigenic in rats. Virology 166: 281–284
Schaeper U, Boyd JM, Verma S, Uhlmann E, Subramanian T, Chinnadurai G (1995) Molecular cloning and characterization of a cellular phosphoprotein that interacts with a conserved C-terminal domain of adenovirus E1A involved in negative modulation of oncogenic transformation. Proc Natl Acad Sci USA 92: 1046710471
Schaley J, O’Connor RJ, Taylor LJ, Bar-Sagi D, Hearing P (2000) Induction of the cel- lular E2F-1 promoter by the adenovirus E4–6 7 protein. J Virol 74: 2084–2093
Schiedner G, Hertel S, Kochanek S (2000) Efficient transformation of primary human amniocytes by El functions of ad5: generation of new cell lines for adenoviral vector production. Hum Gene Ther 11: 2105–2116
Schlehofer J, zur Hausen H (1982) Induction of mutations within the host cell genome by partially inactivated Herpes Simplex Virus type 1. Virology 122: 471–475
Schramayr S, Caporossi D, Mak I, Jelinek T, Bacchetti S (1990) Chromosomal damage induced by human adenovirus type 12 requires expression of the E1B 55-kilodalton viral protein. J Virol 64: 2090–2095
Schrier PI, Bernards R, Vaessen RT, Houweling A, van der Eb AJ (1983) Expression of class I major histocompatibility antigens switched off by highly oncogenic adenovirus 12 in transformed rat cells. Nature 305: 771–775
Shaw G, Morse S, Ararat M, Graham FL (2002) Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells. Faseb J 16: 869–871
Shen Y, Shenk T (1994) Relief of p53-mediated transcriptional repression by the adenovirus E1B 19-kDa protein or the cellular Bd-2 protein. Proc Natl Acad Sci USA 91: 8940–8944
Shen Y, Zhu H, Shenk T (1997) Human cytomegalovirus IE1 and IE2 proteins are mutagenic and mediate “hit-and-run” oncogenic transformation in cooperation with the adenovirus E1A proteins. Proc Natl Acad Sci USA 94: 3341–3345
Shenk T (1996) Adenoviridae: the viruses and their replication. In: Fields BN, Knipe DM, Howley PM (eds) Virology, Third ed, vol. 2. Lippincott-Raven, New York, pp 2111–2148
Shepherd SE, Howe JA, Mymryk JS, Bayley ST (1993) Induction of the cell cycle in baby rat kidney cells by adenovirus type 5 E1A in the absence of E1B and a possible influence of p53. J Virol 67: 2944–2949
Shiroki K, Hashimoto S, Saito I, Fukui Y, Kato H, Shimojo H (1984) Expression of the E4 gene is required for establishment of soft-agar colony-forming rat cell lines transformed by the adenovirus 12 El gene. J Virol 50: 854–863
Singh P, Wong SH, Hong W (1994) Overexpression of E2F-1 in rat embryo fibroblasts leads to neoplastic transformation. EMBO J 13: 3329–3338
Skinner GR (1976) Transformation of primary hamster embryo fibroblasts by type 2 simplex virus: evidence for a “hit and run” mechanism. Br J Exp Pathol 57: 361376
Smirnov DA, Hou S, Liu X, Claudio E, Siebenlist UK, Ricciardi RP (2001) COUP-TFII is upregulated in adenovirus typel2 tumorigenic cells and is a repressor of MHC class I transcription. Virology 284: 13–19
Smith GCM, Jackson SP (1999) The DNA-dependent protein kinase. Genes Dev 13: 916–934
Sprengel J, Schmitz B, Heuss Neitzel D, Doerfler W (1995) The complete nucleotide sequence of the DNA of human adenovirus type 12. Curr Top Microbiol Immunol 199: 189–274
Steegenga WT, Riteco N, Jochemsen AG, Fallaux FJ, Bos JL (1998) The large E1B protein together with the E4orf6 protein target p53 for active degradation in adenovirus infected cells. Oncogene 16: 349–357
Sternsdorf T, Grotzinger T, Jensen K, Will H (1997) Nuclear dots: actors on many stages. Immunobiology 198: 307–331
Stevens JL, Cantin GT, Wang G, Shevchenko A, Berk AJ (2002) Transcription control by E1A and MAP kinase pathway via Sur2 mediator subunit. Science 296: 755–758
Stracker TH, Carson CT, Weitzman MD (2002) Adenovirus oncoproteins inactivate the Mrel 1 Rad50 NBS1 DNA repair complex. Nature 418: 348–352
Subramanian T, La Regina M, Chinnadurai G (1989) Enhanced ras oncogene mediated cell transformation and tumorigenesis by adenovirus 2 mutants lacking the C-terminal region of Ela protein. Oncogene 4: 415–420
Subramanian T, Malstrom SE, Chinnadurai G (1991) Requirement of the C-terminal region of adenovirus Ela for cell transformation in cooperation with Elb. Oncogene 6: 1171–1173
Takayesu D, Teodoro JG, Whalen SG, Branton PE (1994) Characterization of the 55 Kadenovirus type 5 E1B product and related proteins. J Gen Virol 75: 789–798
Tuber B, Dobner T (2001) Molecular regulation and biological function of adenovi-rus early genes: the E4 ORFs. Gene 278: 1–23
Täuber B, Dobner T (2001) Adenovirus early E4 genes in viral oncogenesis. Oncogene 20: 7847–7854
Telling GC, Williams J (1993) The EiB 19-kilodalton protein is not essential for transformation of rodent cells in vitro by adenovirus type 5. J Virol 67: 1600–1611
Telling GC, Williams J (1994) Constructing chimeric type 12 type 5 adenovirus E1A genes and using them to identify an oncogenic determinant of adenovirus type 12. J Virol 68: 877–887
Teodoro JG, Halliday T, Whalen SG, Takayesu D, Graham FL, Branton PE (1994) Phosphorylation at the carboxy terminus of the 55-kilodalton adenovirus type 5 E1B protein regulates transforming activity. J Virol 68: 776–786
Teodoro JG, Shore GC, Branton PE (1995) Adenovirus E1A proteins induce apoptosis by both p53-dependent and p53-independent mechanisms. Oncogene 11: 467–474
Teodoro JG, Branton PE (1997) Regulation of p53-dependent apoptosis, transcriptional repression, and cell transformation by phosphorylation of the 55-kilodalton E1B protein of human adenovirus type 5. J Virol 71: 3620–3627
Terris B, Baldin V, Dubois S, Degott C, Flejou J-F, Hénin D, Dejean A (1995) PML nuclear bodies are general targets for inflammation and cell proliferation. Cancer Res 55: 1590–1597
Thomas A, White E (1998) Suppression of the p300-dependent mdm2 negative-feedback loop induces the p53 apoptotic function. Genes Dev 12: 1975–1985
Thomas DL, Shin S, Jiang BH, Vogel H, Ross MA, Kaplitt M, Shenk TE, Javier RT (1999) Early region 1 transforming functions are dispensable for mammary tumorigenesis by human adenovirus type 9. J Virol 73: 3071–3079
Thomas DL, Schaack J, Vogel H, Javier RT (2001) Several E4 region functions influ-ence mammary tumorigenesis by human adenovirus type 9. J Virol 75: 557–568
Tigges MA, Raskas HJ (1984) Splice junctions in adenovirus 2 early region 4 mRNAs:multiple splice sites produce 18 to 24 RNAs. J Virol 50: 106–117
Trentin JJ, Yabe Y, Taylor G (1962) The quest for human cancer viruses: a new approach to an old problem reveals cancer induction in hamster by human adenoviruses. Science 137: 835–849
Turnell AS, Grand RJ, Gorbea C, Zhang X, Wang W, Mymryk JS, Gallimore PH (2000) Regulation of the 26S proteasome by adenovirus E1A. EMBO J 19: 47594773
van den Heuvel SJL, van Laar T, Kast WM, Melief CJM, Zantema A, van der Eb AJ (1990)Association between the cellular p53 and the adenovirus 5 E1B-55kd proteins reduces the oncogenicity of Ad-transformed cells. EMBO J 9: 2621–2629
van den Heuvel SJL, The SI, Klein B, Jochemsen AG, Zantema A, van der Eb AJ (1992) p53 shares an antigenic determinant with proteins of 92 and 150 kilodaltons that maybe involved in senescence of human cells. J Virol 66: 591–595
van den Heuvel SJL, van Laar T, The I, van der Eb AJ (1993) Large E1B proteins of adenovirus types 5 and 12 have different effects on p53 and distinct roles in cell transformation. J Virol 67: 5226–5234
van der Eb AJ, Zantema A (1992) Adenovirus oncogenesis. In: Dörfler W, Böhm P (eds) Malignant transformation by DNA viruses. VCH, Weinheim, pp 115–140
Virtanen A, Gilardi P, Naslund A, LeMoullec JM, Pettersson U, Perricaudet M (1984) mRNAs from human adenovirus 2 early region 4. J Virol 51: 822–831
Virtanen A, Pettersson U (1985) Organization of early region IB of human adenovirus type 2: identification of four differentially spliced mRNAs. J Virol 54: 383–391
Wang G, Berk AJ (2002) In vivo association of adenovirus large E1A protein with the human mediator complex in adenovirus-infected and -transformed cells. J Virol 76: 9186–9193
Waubke R, zur Hausen H, Henle W (1968) Chromosomal and autoradiographic studies of cells infected with herpes simplex virus. J Virol 2: 1047–1054
Weiden MD, Ginsberg HS (1994) Deletion of the E4 region of the genome produces adenovirus DNA concatemers. Proc Natl Acad Sci USA 91: 153–157
Weiss RS, McArthur MJ, Javier RT (1996) Human adenovirus type 9 E4 open reading frame 1 encodes a cytoplasmic transforming protein capable of increasing the oncogenicity of CREF cells. J Virol 70: 862–872
Weiss RS, Lee SS, Prasad BV, Javier RT (1997a) Human adenovirus early region 4 open reading frame 1 genes encode growth-transforming proteins that may be distantly related to dUTP pyrophosphatase enzymes. J Virol 71: 1857–1870
Weiss RS, Gold MO, Vogel H, Javier RT (1997b) Mutant adenovirus type 9 E4 ORF1 genes define three protein regions required for transformation of CREF cells. J Virol 71: 4385–4394
Weiss RS, Javier RT (1997) A carboxy-terminal region required by the adenovirus type 9 E4 ORF1 oncoprotein for transformation mediates direct binding to cellular polypeptides. J Virol 71: 7873–7880
White E, Cipriani R (1990) Role of adenovirus E1B proteins in transformation: altered organization of intermediate filaments in transformed cells that express the 19-kilodalton protein. Mol Cell Biol 10: 120–130
White E (2001) Regulation of the cell cycle and apoptosis by the oncogenes of adenovirus. Oncogene 20: 7836–7846
Whittaker JL, Byrd PJ, Grand RJ, Gallimore PH (1984) Isolation and characterization of four adenovirus type 12-transformed human embryo kidney cell lines. Mol Cell Biol 4: 110–116
Wienzek S, Roth J, Dobbelstein M (2000) E1B 55-kilodalton oncoproteins of adenovirus types 5 and 12 inactivate and relocalize p53, but not p51 or p73, and cooperate with E4orf6 proteins to destabilize p53. J Virol 74: 193–202
Williams J, Williams M, Liu C, Telling G (1995) Assessing the role of E1A in the differential oncogenicity of group A and group C human adenoviruses. Curr Top Microbiol Immunol 199: 149–175
Williams JF, Young CSH, Austin PE (1974) Genetic analysis of human adenovirus type 5 in permissive and nonpermissive cells. Cold Spring Harbor Symp Quant B 39: 427–437
Williams JF, Galos RS, Binger MH, Flint SJ (1979) Location of additional early regios within the left quarter of the adenovirus genome. Cold Spring Harbor Symp Quant Biol 44: 353–366
Wold WSM, Tollefson AE (1998) Adenovirus E3 proteins: 14.7 K, RID, and gp19 K inhibit immuneinduced cell death; adenovirus death protein promotes cell death. Semin Virol 8: 515–523
Xu G, Livingston DM, Krek W (1995) Multiple members of the E2F transcription fac- tor family are the products of oncogenes. Proc Natl Acad Sci USA 92: 1357–1361
Yamano S, Tokino T, Yasuda M, Kaneuchi M, Takahashi M, Niitsu Y, Fujinaga K, Yamashita T (1999) Induction of transformation and p53-dependent apoptosis by adenovirus type 5 E4orf6 7 cDNA. J Virol 73: 10095–10103
Yew PR, Kao CC, Berk AJ (1990) Dissection of functional domains in the adenovirus 2 early 1B 55 K polypeptide by suppressor-linker insertional mutagenesis. Virology 179: 795–805
Yew PR, Berk AJ (1992) Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein. Nature 357: 82–85
Yew PR, Liu X, Berk AJ (1994) Adenovirus E1B oncoprotein tethers a transcriptional repression domain to p53. Genes Dev 8: 190–202
Yewdell JW, Bennink JR, Eager KB, Ricciardi RP (1988) CTL recognition of adenovirus-transformed cells infected with influenza virus: lysis by anti-influenza CTL parallels adenovirus-12-induced suppression of class I MHC molecules. Virology 162: 236–238
Yu A, Fan HY, Liao D, Bailey AD, Weiner AM (2000) Activation of p53 or loss of the Cockayne syndrome group B repair protein causes metaphase fragility of human Ul, U2, and 5S genes. Mol Cell 5: 801–810
Zalmanzon ES (1987) Transforming and oncogenic properties of the adenovirus genome. Eksp Onkol 9: 3–8
Zantema A, Fransen JA, Davis OA, Ramaekers FC, Vooijs GP, DeLeys B, van der Eb AJ (1985a) Localization of the E1B proteins of adenovirus 5 in transformed cells, as revealed by interaction with monoclonal antibodies. Virology 142: 44–58
Zantema A, Schrier PI, Davis OA, van Laar T, Vaessen RT, van der Eb AJ (1985b) Adenovirus serotype determines association and localization of the large E1B tumor antigen with cellular tumor antigen p53 in transformed cells. Mol Cell Biol 5: 3084–3091
Zerler B, Moran B, Maruyama K, Moomaw J, Grodzicker T, Ruley HE (1986) Adenovirus E1A coding sequences that enable ras and pmt oncogenes to transform cultured primary cells. Mol Cell Biol 6: 887–899
Zhang S, Mak S, Branton PE (1992) Overexpression of the E1B 55-kilodalton (482R) protein of human adenovirus type 12 appears to permit efficient transformation of primary baby rat kidney cells in the absence of the E1B 19-kilodalton protein. J Virol 66: 2302–2309
Zheng P, Guo Y, Niu Q, Levy DE, Dyck JA, Lu S, Sheiman LA, Liu Y (1998) Proto-oncogene PML controls genes devoted to MHC class I antigen presentation. Nature 396: 373–376
Zhong S, Hu P, Ye TZ, Stan R, Ellis NA, Pandolfi PP (1999) A role for PML and the nuclear body in genomic stability. Oncogene 18: 7941–7947
zur Hausen H (1967) Induction of specific chromosomal aberrations by adenovirus type 12 in human embryonic kidney cells. J Virol 1: 1174–1185
zur Hausen H (1996) Papillomavirus infections—a major cause of human cancers. Biochim Biophys Acta 1288: F55 - F78
zur Hausen H (1996) Viruses in human tumors—reminiscences and perspectives. Adv Cancer Res 68: 1–22
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Endter, C., Dobner, T. (2004). Cell Transformation by Human Adenoviruses. In: Doerfler, W., Böhm, P. (eds) Adenoviruses: Model and Vectors in Virus-Host Interactions. Current Topics in Microbiology and Immunology, vol 273. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-05599-1_6
Download citation
DOI: https://doi.org/10.1007/978-3-662-05599-1_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-05715-1
Online ISBN: 978-3-662-05599-1
eBook Packages: Springer Book Archive